myVisionTrack™ is an accurate, portable, and user-friendly system that enable patients with retinal diseases to quickly and efficiently monitor their own vision function at home.
By using proprietary VAS software and a shape discrimination test implemented on a handheld electronic platform, myVisionTrack allows patients with degenerative eye disease such as diabetic retinopathy (DR) and Age Related Macular Degeneration (AMD) to quickly and accurately test their own visual function at home.
In the past decade, new therapies have been developed for these degenerative eye diseases, but timely treatment is critical to their effectiveness. Unfortunately most patients are unable to self-detect the renewed disease activity with the paper eye charts (Amsler Grid) which are today’s standard. There is a very large need for an easy, quick and accurate test which patients can use to monitor their own disease progression.
Patients can self-monitor their condition at home. Results of the test are stored, automatically compared with prior test results. In the event that a significant change is detected, the physician would be notified to review the data to determine if the patient needs to come in sooner for a check-up. With myVisionTrack, patients can now monitor their vision function in between regular visits to eye-care professional to help insure they obtain timely care and treatments.
myVisionTrack is available by prescription only and its initial usage would be for Clinical Drug Trials and small pilot deployments – thus, it will not be commercially available until the 4th quarter of 2013.